STAR-Liège Clinical Trial Interim Results: Safe and Effective Glycemic Control for All. (2019)
Type of ContentConference Contributions - Published
While the benefits of glycemic control for critically ill patients are increasingly demonstrated, the ability to deliver safe, effective control to intermediate target ranges is widely debated due to the increased risk of hypoglycemia. This study analyzes interim clinical trial results of the fully computerized model-based Stochastic TARgeted (STAR) glycemic control framework at the University Hospital of Liège, Belgium. Patients with dysglycemia were randomly assigned to the full version of STAR, modulating both insulin and nutrition inputs, or STAR-IO, an insulin only version of STAR. Both arms target the normoglycemic 80-145 mg/dL (4.4-8.0 mmol/L) band. Results are further compared to retrospective data from 20 patients under the standard unit protocol targeting a higher 100-150 mg/dL (5.6-8.3 mmol/L) band. Much higher time in target band is provided under the full version of STAR, with similar safety and significantly lower incidence of mild hyperglycemia (blood glucose > 145 mg/dL or 8.0 mmol/L) and severe hyperglycemia (blood glucose > 180 mg/dL or 10.0 mmol/L). As a result, lower median blood glucose levels are safely and consistently achieved with lower glycemic variability, suggesting STAR's potential to improve clinical outcomes. These interim results show the possibility to achieve safe, effective control for all patients using STAR, and suggest glycemic control to lower targets could be beneficial.
CitationUyttendaele V, Knopp JL, Pirotte M, Morimont P, Lambermont B, Shaw GM, Desaive T, Chase JG (2019). STAR-Liège Clinical Trial Interim Results: Safe and Effective Glycemic Control for All.. United States: 2019 41st Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 23/07/2019-27/07/2019. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. 2019. 277-280.
This citation is automatically generated and may be unreliable. Use as a guide only.
ANZSRC Fields of Research40 - Engineering::4003 - Biomedical engineering
42 - Health sciences::4203 - Health services and systems::420319 - Primary health care
Rights© 2019 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.
Showing items related by title, author, creator and subject.
Development and pilot trial results of stochastic targeted (STAR) glycemic control in a medical ICU Fisk, L.; Le Compte, A.J.; Shaw, Geoff; Penning, S.; Desaive, T.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Accurate glycemic control (AGC) is difficult due to excessive hypoglycemia risk. Stochastic TARgeted (STAR) glycemic control forecasts changes in insulin sensitivity to calculate a range of glycemic outcomes for an insulin ...
Second Pilot Trials of the STAR-Liege Protocol for Tight Glycemic Control in Critically Ill Patients Penning, S.; Le Compte, A.J.; Massion, P.; Moorhead, K.T.; Pretty, C.G.; Preiser, J.C.; Shaw, Geoff; Suhaimi, F.; Desaive, T.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2012)Critically ill patients often present increased insulin resistance and stress-induced hyperglycemia. Tight glycemic control aims to reduce blood glucose (BG) levels and variability while ensuring safety from hypoglycemia. ...
Towards personalized intensive care decision support using a Bayesian network: A multicenter glycemic control study Abu-Samah A; Razak NNA; Suhaimi FM; Jamaludin UK; Chase, Geoff (The Institute of Electronics Engineers of Korea, 2019)Personalized treatment in glycemic control (GC) is a visibly promising research area that requires improved mechanisms providing patient-specific procedures to enable complicated decision support. Available per-patient ...